1. Scrip
  2. >>COVID-19

Coronavirus Update: $8bn International Fund For Vaccines Created

Leaders Call For Unity Amid Rising US and China Tensions

 
• By Scrip Team

Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.

Vonder_Leyen_Ursula
European Commission president Ursula von der Leyen is leading the creation of the international fund • Source: European Commission

World leaders have pledged €7.4 billion ($8.07 bn) in a digital fundraising event to raise money for a global fund to develop coronavirus vaccines and therapies.

More from COVID-19

More from Scrip

Asia Deal Watch: Daiichi Taps Into Wayfinder’s RNA-Encoding Platform

 
• By Jung Won Shin, Lisa Takagi, Joseph Haas, Anju Ghangurde, and Vibha Ravi

Plus deals involving Elix/PRISM, Rege/Syros, Kaken/KalVista, Dr. Reddy’s/Aurigene/Edity, Nissan Chemical/Sanwa, Lupin/Renascience, Shionogi/Link Medicine, Abbisko/Merck & Co., Ono/Reborna and Apollomics/LaunXp.

Cancer Retains Top Spots In Alliance Deal Volume, Value

 
• By Joseph Haas

Cancer assets drove the highest percentage of biopharma alliance dealmaking in 2024, tripling the frequency of the next highest therapeutic category, neurology.

Oncology’s Most Eligible Unpartnered Assets

 
• By Edwin Elmhirst

Evaluate's top five unpartnered clinical oncology assets reveals you have to get in early to snap up innovation in the competitive cancer space.